Physician profile
James E Estes
NPI 1285641753
$1,585.69
in general payments reported to CMS, 2019-2025
26 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $86.16 · 2022: $243 · 2023: $372 · 2024: $321 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $214.44 | 2019-2025 | |
| Pfizer INC. | $161.79 | 2022-2023 | |
| Sage Therapeutics, LLC | $131.24 | 2024-2025 | Zurzuvae |
| Novo Nordisk INC | $127.35 | 2019-2025 | Wegovy |
| Exeltis, USA INC. | $126.80 | 2022-2025 | Slynd |
| Optumhealth Care Solutions, LLC | $107.35 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Daiichi Sankyo INC. | $98.69 | 2022-2025 | Injectafer |
| Covidien LP | $72.18 | 2020 | |
| Exact Sciences Corporation | $72.02 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $61.29 | 2025 | Veozah |
| Coopersurgical, INC. | $48.46 | 2019-2024 | Paragard T 380a |
| Medtronic, INC. | $46.63 | 2023 | Ligasure |
| Bayer Healthcare Pharmaceuticals INC. | $39.01 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $38.43 | 2025 | Myfembree |
| Biohaven Pharmaceutical Holding Company LTD. | $36.61 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $30.32 | 2025 | |
| Amag Pharmaceuticals, INC. | $25.24 | 2019 | |
| Sanara Medtech INC. | $22.39 | 2025 | Celleraterx |
| Aspira Women'S Health INC | $20.17 | 2022 | |
| Therapeuticsmd, INC. | $18.53 | 2022 | |
| Bard Access Systems, INC. | $17.89 | 2019 | |
| Organon LLC | $17.33 | 2024 | |
| Avanos Medical | $16.37 | 2023 | On-Q* Pump and Accessories |
| Meditrina | $16.28 | 2023 | |
| Merck Sharp & Dohme LLC | $13.08 | 2019 | |
| Allergan, INC. | $5.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Estes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.